Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7960593

COc1ccc2nc3cc(Cl)ccc3c(NCCNc3c4ccc(Cl)cc4nc4ccc(O)cc34)c2c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.67
GSR P00390 7/20 0.64
KMT2A Q03164 2/20 0.61
TDP1 Q9NUW8 2/20 0.61
MEN1 O00255 1/20 0.61
MBNL1 Q9NR56 1/20 0.60
PHLPP2 Q6ZVD8 2/20 0.56
HDAC1 Q13547 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
KDM4E B2RXH2 2/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
MAPK1 P28482 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
GPR55 Q9Y2T6 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
CYP19A1 P11511 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7877725 0.96 ADORA2A (0.72) ADORA2AGSRKMT2ATDP1MEN1
Trifluoroacetic Acid SCHEMBL7869239 0.93 GSR (0.69) ADORA2AGSRKMT2ATDP1MEN1
Trifluoroacetic Acid SCHEMBL7875800 0.92 GSR (0.72) ADORA2AGSRKMT2ATDP1MEN1
SCHEMBL7874381 0.92 ADORA2A (0.78) ADORA2AGSRKMT2ATDP1MEN1
Trifluoroacetic Acid SCHEMBL7967139 0.91 ADORA2A (0.66) ADORA2AGSRKMT2ATDP1MEN1
Trifluoroacetic Acid SCHEMBL7878018 0.91 ADORA2A (0.52) ADORA2AGSRKMT2ATDP1MEN1
Trifluoroacetic Acid SCHEMBL30227435 0.89 ADORA2A (0.63) ADORA2AGSRKMT2ATDP1MEN1
Trifluoroacetic Acid SCHEMBL30227214 0.89 ADORA2A (0.53) ADORA2AGSRKMT2ATDP1MEN1
Trifluoroacetic Acid SCHEMBL7877818 0.89 ADORA2A (0.53) ADORA2AGSRKMT2ATDP1MEN1
Trifluoroacetic Acid SCHEMBL7956392 0.89 ADORA2A (0.63) ADORA2AGSRKMT2ATDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143235-A1 METHODS AND COMPOSITIONS FOR TREATING CYTOKINE STORM INFECTIONS, INCLUDING COVID-19, BY INHIBITING CCR5/CCL5 INTERACTION IncellDx, Inc. (US) 2023-03-08 EP disclosed
WO-2021222069-A1 METHODS AND COMPOSITIONS FOR TREATING CYTOKINE STORM INFECTIONS, INCLUDING COVID-19, BY INHIBITING CCR5/CCL5 INTERACTION INCELLDX, INC. (US) 2021-11-04 WO disclosed
US-6242459-B1 Substituted bis-acridines and related compounds as CCR5 receptor ligands, anti-inflammatory agents and anti-viral agents SMITHKLINE BEECHAM CORPORATION 2001-06-05 US disclosed